603087.SS Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (3 Jun 2024 @ 01:22):

Gan & Lee Pharmaceuticals., a biopharmaceutical company, engages in the research, development, production, and commercialization insulin analogues primarily in China...

Stats
Today's Volume	6.98M
Average Volume	10.27M
Market Cap	29.19B
EPS	CNY0.160 ( 2024-05-16 )
Last Dividend	CNY0 ( N/A )
Next Dividend	CNY0 ( N/A )
P/E	72.96
ATR14	CNY0.0400 (0.08%)

Volume Correlation

Long: 0.28 (neutral)

Short: -0.50 (weak negative)

Signal:(41.437) Neutral

Gan & Lee Correlation

10 Most Positive Correlations

10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Gan & Lee Correlation - Currency/Commodity

0.56
( weak )

0.59
( weak )

0.00
( neutral )

0.56
( weak )

0.32
( neutral )

Gan & Lee Financials

Annual	2023
Revenue:	CNY2.58B
Gross Profit:	CNY1.79B (69.20 %)
EPS:	CNY0.600

FY	2023
Revenue:	CNY2.58B
Gross Profit:	CNY1.79B (69.20 %)
EPS:	CNY0.600

FY	2022
Revenue:	CNY1.71B
Gross Profit:	CNY1.31B (76.30 %)
EPS:	CNY-0.780

FY	2021
Revenue:	CNY3.61B
Gross Profit:	CNY3.22B (89.03 %)
EPS:	CNY2.59

Financial Reports:

No articles found.

Gan & Lee Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Gan & Lee

Gan & Lee Pharmaceuticals., a biopharmaceutical company, engages in the research, development, production, and commercialization insulin analogues primarily in China. Its products include Basalin, an insulin glargine injection; Prandilin, an insulin lispro injection; Prandilin 25, an insulin lispro; Raplin, an insulin aspart injection; Raplin 30, an insulin aspart 30 injection; and Similin 30, an insulin injection, as well as medical devices. The company was formerly known as Beijing Gan & Lee Biotechnology Co., Ltd. and changed its name to Gan & Lee Pharmaceuticals. in April 2005. Gan & Lee Pharmaceuticals. was founded in 1998 and is headquartered in Beijing, the People's Republic of China.